Abstract  by unknown
JACC February 1997
aortic (1-Ao)preseorsduring ACLS-selective aortic pertueionand oxygenation
(SAPO)with ultra-wified MymerizedbovinehemoglobinOJPW. fvfe~frods:
Randomized, blinded, inte’wentional study usingacanine model of ventricular
fibrillation (VF) with ACLS-SAPO resuscitation. After wchloraiose anesthe-
sia, Ao blood gaaeaand vital signs were normalized. ECG, Ao arch, and right
atrial pressuras were measured continuously. A descending Ao occlusion-
infuaion balloon catheter was placed through the femoral artery. VF was
induced and BLS begun after 10 min. of arrest. Inter-animal differences in
BLS ware minimized by standardization of esophageal pulse pressure and
Ao blood gases. After 13 min. of arrest, the Ao occlusion balloon was in-
flated and EPI [0.01 mg/kg] or PHE [0.5 mg/kg] administered I-Ao. Thia was
followed by oxygenated UPBH (30 ml/kg) infusion over 2 min. and electrical
counterehock. Results: (n = 14) Three of 7 animals receiving EPI had ROSC
versus 7 of 7 animals receiving PHE (p = 0.07). Two animals in the EPI group
were aliva one hour following ROSC versus all 7 animals receiving PHE (p =
0.02). The 4animals in the EPI group that did not achieve ROSCdefibrillated
into paeudo-electromechanicd dissociation. Conclusions: In this model 0.5
mglkg of PHE in conjunction with ACLS-SAPO increased the suvival rate
at one hour, and tended towards improving rates of ROSC as compared to
0.01 mg/kg EPI.
m955169 Long Term Survival Rate After Rasuecitation With
the Uea of Percutaneous Cardiopulmonary
Suppoti
M. Ferrari, K.H. Scholz, G. Wittmann, H. Kreuzer, H.R. Figulla. Dept.
Cardiology.%PulmonologK Uni~ of G&tingen, Germany
Percutaneous cardiopulmonary suppoti (PCPS) offers the opportunity’ to
reestablish circulation in patients (pts) who can not be resuscitated by mn-
venfional meana. As of today, follow-up data of pts who were resuscitated
using pCPS are still lacking. Between October 1990 and July 1996 pCPS
was used in 32 pts in refractory circulato~ arrest in our clinic (age 58 & 10.4
yeare, 9 Q, 23 d). 25 pts (78%) had acute myocerdial infarctions, 2 (6%)
pulmonary emboliams, 2 (6%) ventricular ruptures, 3 (9%) valve fractures.
Standard resuscitation waa performed over 10 to 240 minutes (59 + 43 rein)
before stabilization by pCPS. In 3 pts (99’.)we did not achieve sufficient cir-
culation; in the other 29 pts (91%) cardiopulmonary suppoti was maintained
over 1.5 to 10 hours. 22 pfs (897.) died in the clinical course due to multi-
orgsn failure deapite primarily successful catheter interventions or cardiac
surgery.7 pts (22%) were discharged from hospital without relevant disabling
neurological defect. 3 of them had cardiac surgery (9%), in the other 4 pta
a PTCA was performed (13%). The time of standard resuscitation before
insertion of pCPS in thoae pts who were discharged from hospital was 42 +
22.4 min (mean age 52 + 7 years). After an average follow up of 30 months
4 pts (13%) are still alive. 2 pts died of cardiac failure and 1 pt of neoplasm
during follow up. By use of PCPS in combination with interventional and
surgical procedures it is possible to achieve a success rate of 22% if other
means of resuscitation do not suffice. The relatively poor long term survival
underlines the need for early complete revascularfsation in those pta surviv-
ing the first ischemic arrest. Due to economic bending and the relatively poor
long term auwival rate the decision for using PCPS in resuscitation should
be considered in young pts.
m Arrest955170 A Randomized Trial of Magnesium in Cardiac
M.C. Thel, S.E. McNulty, A.L. Armstrong, R.M. Califf, C.M. O’Connor. Duka
University Medical CenteL Durham, NC, USA
We conducted a randomized, double-blind trial comparing magnesium to
placebo in the management of in-hospital cardiac arrest. Patients at least
18 yeare old in the general warda and intensive care units were eligible;
exclusion criteria were advanced atrioventricular block and clinic’alindication
for magnesium. The primary endpoint was return of spontaneous circulation
(ROSC)defined bytheatteinment of any blcaf pressure or palpable pulse for
at least 1 hour following cardiac arrest. Baseline clinical characteristics and
initial rhythmawere similar between the groups. In univariate and multivariate
models only an initial rhythm of ventricular fibrillation or tachycardia was a
predictor of ROSC orsuwival to hospital discharge. The results are indicatad
in the table:
Outcome Magnesium Placebo OR 95°hCl
n. 76 n =60
ROSC 41 (54) 48 (60) 0.78 0.41-1.47
24 hrawvival 33 (43) 40 (50) 0.77 0.41-1.44
Discharged 16 (21) 17 (21) 0.99 0.4S-2.13
Kamofsfryscore 70% 40% p=0041
Valussareexpressedsanumbarofpatienta(0/4
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Our atudy demonstrated no improvement in resuscitation, 24-hour sur-
vival, or auwival to hospital diacharge in hospitalized patients with cardiac
arrest who were treated with empiric magnesium supplementation compared
with placebo. Patients assigned to magnesium who suwived to discharge
had improved functional status as measured by the Karnofsky performance
score.
-1 TranathoracicDefibrillationU$ingahJove13
Electrode Configuration With Multivector
Overlapping Pulsea
J.J. AlIan, R.S. Smith, R.E. Kerber. University oflowa, Iowa City, 1A,USA
Wehaveshown in experimental animals that encircling overlapping truncated
exponential shockwaveforms using6 electrode pads placed around thachest
improve shock success for ventricular fibrillation (VF). However, the need for
multiple capacitors and a total of 6 electrode pads would make this clinically
cumbersome. Our purpose was to evaluate the defibrillation efficacy of a new
3 pad electrode configuration using a single capacitor. Three new truncated
exponential encircling overlapping waveforms were designed specifically for
this configuration: 7 vector, 7 ms duration (EOV7); 3 vector, 6 ms duration
(EOV3); 5 vector, 10 ms duration (EOV5). Damped sinusoidal (DS) and
Biphasic single pathway 5 ms positive, 3 ms negative (Bi) waveforms were
used for comparison. VF was induced and maintained unsupported for 15
seconds in 7 closed chest swine.
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* p <0.05, compared to DS, Mean + SEM
Thus, novel multivecfor overlapping waveforms which can be delivered
from a simple 3 electrode configuration are more effective than the atendard
damped sinusoidal waveform for transthoracic defibrillation.
1955-1721 Temporary Caf’diacPacingin CCUusing
Balloon-Flotation Electrode Catheters: a
Randomised Comparison with Conventional
Sami-Rigid Electrode Catheters
J.D. Fergueon, A.P. Banning, Y. Bashir. Depanmerrt of Cardiology John
Radcliffe Hospital, Oxford, England
Emergency transvenoua cardiac pacing in the CCU is offen performed by
junior medical staff with limited invasive experience resulting in prolonged
procedures and a high incidence of complications. Balloon-flotation (B-F)
pacing catheters require less manipulation than conventional semi-rigid (S-
R) alectrode catheters and maybe easier for lees experienced operators to
insart.We prospectively randomised 40 patients (20 M:20 F,mean age72yrs)
undergoing temporary ventricular-demand pacing to S-R or B-F electrode
catheters inserted with fluoroacopic guidance. Indications for pacing were
AV block with acute Ml (n = 16), AV block without recent iechemia (n =
19) and overdrive pacing for VT (n = 5). All procedures were performed by
Residenta/Fellows in Cardiology or Internal Medicine. End-points included
procedureduration (excluding venous access), fluoroacopytime and diastolic
threahold at implanU24 hrs. Catheter position was independently assessed
from the post-inaerlion chest X-ray and categorised as satisfactory (Satis.)
or-suboptimal.
Cardiac pacing was established in all cases with a threshold s 1.0 V at 2
ms pulee width (no difference between groups at implant/24 hre). Complica-
tions in the S-R group were displacement (n= 3), RV perforation (n =1) and
in the B-F group were displacement (n = 1).
Duration(sacs) Fluoroscope(sees) Satia.poaition
B-F 430* 150 153+ 160 100%
S-R S70* 910 328+ 300 60”/0
pvalue <0,002 <0.01 <0.001
Cone/usions:Using B-Fcatheters resulted in shorter insertion procedures,
with less fluoroscope,better final catheter positions and fewer complications.
